Radiofrequency ablation of drug-resistant cancer cells using molecularly targeted carboxyl-functionalized biodegradable graphene.

Authors :: Sasidharan A
Sivaram AJ
Retnakumari AP
Chandran P
Malarvizhi GL
Nair S
Koyakutty M
Source :: Advanced healthcare materials [Adv Healthc Mater] 2015 Apr 02; Vol. 4 (5), pp. 679-84. Date of Electronic Publication: 2015 Jan 13.
Publication Year :: 2015
Abstract: Under ultralow radiofrequency (RF) power, transferrin-conjugated graphene nanoparticles can thermally ablate drug- or radiation-resistant cancer cells very effectively. The results suggest that graphene-based RF hyperthermia can be an efficient method to manage drug-/radiation-resistant cancers.<br /> (© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)

Subjects :: Antineoplastic Agents chemistry
Biocompatible Materials chemistry
Catheter Ablation
Cell Line, Tumor
Drug Resistance, Neoplasm
Graphite chemistry
Humans
Microscopy, Confocal
Antineoplastic Agents pharmacology
Biocompatible Materials pharmacology
Cell Survival drug effects
Cell Survival radiation effects
Graphite pharmacology
Radio Waves

Full Text Access

Tools